U.S. markets open in 24 minutes

CymaBay Therapeutics, Inc. (CBAY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.1900-0.1100 (-2.56%)
At close: 4:00PM EDT

4.1000 -0.09 (-2.15%)
Pre-Market: 9:04AM EDT

Sign in to post a message.
  • G
    Go Heels
    March 13,2021 , Piper Sandler reaffirms buy rating for Cbay with $12 target.
  • G
    Go Heels
    The 10 analysts offering 12-month price forecasts for Cymabay Therapeutics Inc have a median target of 12.50, with a high estimate of 20.00 and a low estimate of 10.00. .....https://money.cnn.com/quote/forecast/forecast.html?symb=cbay
  • G
    Go Heels
    Oppenheimer assigned a buy recommendation or CBAY with a $14 target price.
  • G
    Go Heels
    BlackRock has a position in CBAY worth $30.9 million .
  • l
    linette
    There is a big need of liver inflammation treatments.
  • S
    Silva
    lets rock
  • j
    james
    I think what is hurting the share price is the utter lack of communication from the company. No news on any trials, no information on when earnings will be, no information of any kind. It’s been almost 3 months without anything...No wonder people are selling their shares. They should put something out just to let everyone know they are making some sort of progress. Cmon CBAY board let us know your alive!
  • j
    james
    It seems as though the earnings report should have been released by now...Does anyone have any info on this?
  • B
    BillaBill
    so I just got a free share from robinhood did a lil dd and correct me if I'm wrong but all I see as of right now is a company borrowing alot of money with no product available yet to sell and make profits. Or I'm I missing something? btw not bashing just inquiring
  • s
    scava10247
    Like Yogi said IT AIN'T OVER TILL IT'S OVER BUT THIS ONE IS OVER. I've been in since $3.20 ,left at $4.50. not going to make alot but I'm Out of CBAY
  • G
    Go Heels
    Seems the 5,160,000 shares that were reported shorted on January 29th are making money.
  • I
    Ivan
    CymaBay is developing seladelpar, a potent, selective, orally active PPARδ agonist for patients with primary biliary cholangitis (PBC). Seladelpar has received an orphan designation from the US Food and Drug administration (FDA) and the European Medicine Agency (EMA). Seladelpar also received Breakthrough Therapy Designation from the FDA for early stage PBC and PRIority MEdicines status from the EMA.
  • W
    William
    No bottom
  • B
    Bill
    Think we will get some news soon.....
  • G
    Go Heels
    March 8th, 2021 , Zacks upgraded CBAY from sell to hold.
  • J
    JAVIAN
    Cbay has plenty cash and no debt. Just bought 3k shares.... LFG
  • G
    Go Heels
    On marketwatch, they reported that as of Jan 29th, short interest was up +31%, totaling 5,160,000 shares of CBAY shorted.
  • s
    scava10247
    Big Hat No Cattle!
    Bearish
  • c
    chris
    conference next week! easy peasy lemon squeezey!